Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Diseases Hereditary
• Graves Disease
• Graves Ophthalmopathy
• Hyperthyroidism
• Thyroid-associated Ophthalmopathy

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Graves Ophthalmopathy, Graves Disease | Phase 2 | Status: UNKNOWN